• Skip to main content
  • Skip to navigation
  • Accessibility
  • Contact Us
Government of Western Australia Crest
Government of Western Australia
Government of Western Australia Crest

Additional Menu

  • Accessibility
  • Contact us
Go to WA Government search
  • About SMHS
    • Health Service Board
    • Strategic focus
      • Vision and values
      • Strategic Plan
      • Annual Report
      • Environmental sustainability
      • Innovation
    • Executive
    • Conduct and standards
    • Freedom of Information
    • Governance
    • SMHS Excellence Awards
    • Contact SMHS
  • Our services
    • Our hospitals
    • Elective surgery
      • Contracted medical practitioners
    • Outpatients
    • COVID-19 information
      • SMHS staff self-reporting
    • Aboriginal health
    • Mental health
      • Kara Maar
      • Peel Mental Health Taskforce
    • Health promotion
      • Our priorities
      • Public health planning
    • Community Services
    • Health care snapshot
    • SMHS Online Services Portal
    • Western Australian Limb Service for Amputees
    • Library and Information Service
  • Our care
    • Safe, quality care
      • Reduce your falls risk
      • Preventing pressure injuries
      • Supporting patients with cognitive impairment
      • Understanding delirium
      • Hand hygiene
      • MySay healthcare survey
      • Healthcare associated infections
      • "What matters to you?"
    • Understanding where you will receive care
    • For overseas visitors and students
    • Patient rights
    • Patient stories
    • Private patients
    • Support for carers
      • If you can't visit an older patient
  • Our community
    • Consumer experience
    • Partnering with consumers
      • Community advisory councils
      • 'Put it to the People' engagement platform
    • Engaging with our community
      • GP Engage
      • Fiona Wood Public Lectures
      • Voluntary assisted dying podcasts
      • Health Stories podcasts
    • Disability access and inclusion
      • DAIP strategies
      • DAIP initiatives
      • Supporting people with disability
    • SMHS HealthReady Pipeline
      • About HealthReady
      • Get involved in HealthReady
      • Current HealthReady projects
    • Our volunteers
    • Events
  • Our research
    • About research at SMHS
    • Current research
      • Allied Health Research Unit
      • Nursing and Midwifery Research Unit
    • Our research stories
    • For researchers
      • SMHS Research Integrity Advisors
    • Participate in our research
      • Valuing the consumer voice
  • Work with us
    • Career opportunities
      • Allied health and health professionals
      • Clinical academics
      • Corporate and non-clinical careers
      • Medical
      • Mental health
      • Nursing and midwifery
    • Employee benefits
    • Apply for a job
    • Living in WA
  • News
  1. Home
  2. News
  3. 2024
  4. 07
  5. 09
  6. MoST-TAP trial a possible game-changer for rare cancer patients

MoST-TAP trial a possible game-changer for rare cancer patients

MoST-TAP trial a possible game-changer for rare cancer patients

Fiona Stanley Hospital Medical Oncology Research Officer Trish Barrett and Head of Service, Medical Oncology Dr Wei-Sen Lam stand outside a building FSH Medical Oncology Research Officer Trish Barrett and Head of Service, Medical Oncology Dr Wei-Sen Lam.
10/07/2024

Patients with uncommon and rare cancers may be able to join a new clinical trial at Fiona Stanley Hospital (FSH) that has received ethics approval to trial new drugs that reactivate the body’s anti-tumour immune response and kill cancer cells.

Two immunotherapy drugs will be offered to eligible patients with rare cancers in the multi-centre clinical trial lead by The George Institute in NSW, with FSH as one of the collaborators.

The clinical trial known as ‘MoST-TAP’ will provide patients with rare cancer access to new drugs that may improve their survival rates.

Dr Wei-Sen Lam, Head of Service, Medical Oncology FSH said he hopes these new drugs in the MoST-TAP trial will improve outcomes for cancer patients.

“We have seen similar drugs improve survival in many rare cancer patients and we hope to see patients with these cancers living longer with access to these drugs,” Dr Lam said.

Dr Lam is also the Medical Lead Teletrials at the WA Country Health Service, a program delivering clinical trials closer to home. He said the FSH Medical Oncology Clinical Trials Unit is collaborating with the WA Regional Clinical Trial Coordinating Centre to identify suitable oncology trials for delivery in WA regional health sites to extend trial access to country patients.

Enrolment is underway and recruitment should close mid-2026. For further details email Dr Wei-Sen Lam, Medical Oncology, Fiona Stanley Hospital and Esperance Hospital.

Keep up to date with our news and achievements

Text reads Follow SMHS on Facebook @SouthMetropolitanHealthService
Previous Next
Last Updated: 10/07/2024
  • Facebook
  • LinkedIn
  • YouTube

Footer menu

  • wa.gov.au
  • Copyright
  • Disclaimer
  • Privacy
  • Sitemap
  • Contact Us

Brought to you by the Department of Health, Western Australia

© Government of Western Australia 2018 to